Detalhe da pesquisa
1.
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis.
Am J Hematol
; 99(4): 774-779, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38343062
2.
Prognostic Implications of Circulating Plasma Cell Percentage in Multiple Myeloma and Primary Plasma Cell Leukemia Defined by New Criteria.
Acta Haematol
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626745
3.
Patient-Reported Outcomes in Young Adults with Myeloproliferative Neoplasms.
Acta Haematol
; 146(4): 293-306, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812897
4.
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial.
Am J Hematol
; 97(12): 1510-1519, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054786
5.
Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort study.
BMC Cardiovasc Disord
; 22(1): 175, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428181
6.
Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma.
Blood
; 133(14): 1572-1584, 2019 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30737236
7.
The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma.
Ann Hematol
; 100(5): 1251-1260, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686491
8.
Hereditary intrinsic factor deficiency in China caused by a novel mutation in the intrinsic factor gene-a case report.
BMC Med Genet
; 21(1): 221, 2020 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33172407
9.
Gene mutation profile in patients with acquired pure red cell aplasia.
Ann Hematol
; 99(8): 1749-1754, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594217
10.
IgH translocation with undefined partners is associated with superior outcome in multiple myeloma patients.
Eur J Haematol
; 105(3): 326-334, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32421883
11.
Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China.
Ann Hematol
; 98(1): 143-150, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30209556
12.
Autoimmune disease-associated non-Hodgkin's lymphoma-a large retrospective study from China.
Ann Hematol
; 98(2): 445-455, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370485
13.
hnRNPs and ELAVL1 cooperate with uORFs to inhibit protein translation.
Nucleic Acids Res
; 45(5): 2849-2864, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789685
14.
Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus.
Ann Hematol
; 97(11): 2047-2054, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982851
15.
Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection.
Ann Hematol
; 96(4): 581-587, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28084534
16.
Epinephrine Stimulates Cell Proliferation and Induces Chemoresistance in Myeloma Cells through the ß-Adrenoreceptor in vitro.
Acta Haematol
; 138(2): 103-110, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28848082
17.
Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China.
J Infect Chemother
; 23(6): 360-367, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341518
18.
GATA2 mutation with recurrent haemophagocytic lymphohistiocytosis and panniculitis: a case report.
Rheumatology (Oxford)
; 60(7): e229-e231, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33410496
19.
Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia.
Eur J Haematol
; 96(3): 291-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25996247
20.
Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia.
Ann Hematol
; 99(5): 1141-1143, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32144437